
Sign up to save your podcasts
Or


Send us a text
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts
By Nick Jikomes4.8
7878 ratings
Send us a text
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts

553 Listeners

7,247 Listeners

5,022 Listeners

1,545 Listeners

2,337 Listeners

309 Listeners

706 Listeners

368 Listeners

49 Listeners

245 Listeners

112 Listeners

60 Listeners

117 Listeners

68 Listeners

3,093 Listeners